Antimicrobial resistance presents a critical threat to public health and medicine, projected to account for ten million annual death and a costing a GDP loss of US$100 trillion by 2050. This module which addresses both antimicrobial resistance and drug discovery, is essential in preparing young scientists to address these issues. Lectures on emerging medical technologies are addressed, including principles on mechanisms of action and resistance of antimicrobials as well as the process of drug discovery in Pharma, Biotech and Academia. Topics in drug discovery include conventional conventional screening of small molecules as well as antibody and immunotherapy, CAR-T cell therapy, phage therapy and microbiome based-therapy. Examples using bacteria, parasites and viruses are included.